Genocea Biosciences, a biopharmaceutical company developing personalized cancer immunotherapies has announced the p...
Invivoscribe, announced that on 5 June 2019, the Ministry of Health, Labour and Welfare (MHLW) approved LeukoStrat®&...
Cognizant has agreed to acquire Zenith Technologies, a privately-held life sciences manufacturing technology S...
Ferring Pharmaceuticals and WOOM have announced a collaboration, which aims to improve and shorten the fertility journey...
Stoke Therapeutics, Inc., a biotechnology company that is pioneering a new way to treat the underlying cause of genetic ...
LabCorp and the Mount Sinai Health System has announced another element in their shared goal of improving laborator...
Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and...
After investing more than 100 million U.S. dollars, Sartorius, a leading international partner of biopharmaceutical...
Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General recently met a...
The 6th Global Forum on Nicotine (GFN), the only international conference that focuses on the role of safer nicotin...
Pfizer Inc. has announced positive results from ORAL Shift, a Phase 3b/4 study in adult patients with moderately to seve...
Pfizer Inc. and Array BioPharma Inc. have announced that they have entered into a definitive merger agreement under whic...
Cochlear Limited, the global leader in implantable hearing solutions announced the U.S. Food and Drug Administration's (...
Boehringer Ingelheim and Eli Lilly and Company have announced results of a new post-hoc analysis of data from the EMPA-R...
Flex Pharma has announced that approximately 85% of shares voted to date support the proposed merger with Salarius ...
The MEDICREA Group pioneering the transformation of spinal surgery through Artificial Intelligence, predictive mode...
Univercells, on 13 June 2019, announced that it has been awarded a $14.3M grant by the Bill & Melinda Gates Fou...
Amgen and Allergan plc have announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI™ ...
